UA112974C2 - Нікотиновмісна композиція (варіанти) - Google Patents
Нікотиновмісна композиція (варіанти)Info
- Publication number
- UA112974C2 UA112974C2 UAA201304861A UAA201304861A UA112974C2 UA 112974 C2 UA112974 C2 UA 112974C2 UA A201304861 A UAA201304861 A UA A201304861A UA A201304861 A UAA201304861 A UA A201304861A UA 112974 C2 UA112974 C2 UA 112974C2
- Authority
- UA
- Ukraine
- Prior art keywords
- nicotine
- options
- dosage form
- nicotine composition
- polacrylexic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Розкрито нікотиновмісну тверду пероральну трансмукозальну лікарську форму, що містить терапевтично ефективну кількість нікотину полакрилексу, моногідрат лимонної кислоти, сахарозу та рідку глюкозу, де вміст цукрового сиропу перевищує 95 мас. %. Лікарська форма більш прийнятно перебуває у формі пастилки.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2564MU2010 | 2010-09-16 | ||
PCT/IN2010/000775 WO2012035541A1 (en) | 2010-09-16 | 2010-12-01 | Nicotine containing formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
UA112974C2 true UA112974C2 (uk) | 2016-11-25 |
Family
ID=45831078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201304861A UA112974C2 (uk) | 2010-09-16 | 2010-01-12 | Нікотиновмісна композиція (варіанти) |
Country Status (10)
Country | Link |
---|---|
US (1) | US9180124B2 (uk) |
EP (1) | EP2496083A4 (uk) |
AU (1) | AU2010360967B2 (uk) |
BR (1) | BR112012031102B8 (uk) |
CA (1) | CA2782734C (uk) |
EA (1) | EA025779B1 (uk) |
MX (1) | MX339470B (uk) |
UA (1) | UA112974C2 (uk) |
WO (1) | WO2012035541A1 (uk) |
ZA (1) | ZA201206589B (uk) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9084439B2 (en) | 2011-09-22 | 2015-07-21 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9629392B2 (en) | 2011-09-22 | 2017-04-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US9474303B2 (en) | 2011-09-22 | 2016-10-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
US20130078307A1 (en) | 2011-09-22 | 2013-03-28 | Niconovum Usa, Inc. | Nicotine-containing pharmaceutical composition |
US9763928B2 (en) | 2012-02-10 | 2017-09-19 | Niconovum Usa, Inc. | Multi-layer nicotine-containing pharmaceutical composition |
US9044035B2 (en) | 2012-04-17 | 2015-06-02 | R.J. Reynolds Tobacco Company | Remelted ingestible products |
ES2471665B1 (es) * | 2012-12-21 | 2015-03-12 | Farmalider Sa | Producto sustitutivo del tabaco |
EP3117826A4 (en) * | 2014-03-11 | 2017-09-13 | Farmalider, S.A. | Tobacco substitute product |
CN111226941B (zh) * | 2020-02-15 | 2021-08-20 | 浙江大学 | 一种防治作物害虫的植物源杀虫剂 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8317576D0 (en) | 1983-06-29 | 1983-08-03 | Shaw A S W | Consumer tobacco products |
GB8615676D0 (en) | 1986-06-26 | 1986-07-30 | Stoppers Co Ltd | Nicotine containing lozenge |
US5525351A (en) * | 1989-11-07 | 1996-06-11 | Dam; Anders | Nicotine containing stimulant unit |
US5110605A (en) | 1990-08-21 | 1992-05-05 | Oramed, Inc. | Calcium polycarbophil-alginate controlled release composition and method |
US5549906A (en) | 1993-07-26 | 1996-08-27 | Pharmacia Ab | Nicotine lozenge and therapeutic method for smoking cessation |
US5362496A (en) | 1993-08-04 | 1994-11-08 | Pharmetrix Corporation | Method and therapeutic system for smoking cessation |
HU224035B1 (hu) | 1996-05-13 | 2005-05-30 | Novartis Consumer Health S.A. | Bukkális adagolórendszer |
PL364621A1 (en) | 2001-03-26 | 2004-12-13 | Smithkline Beecham Corporation | Nicotine-containing oral dosage form |
FR2823974B1 (fr) * | 2001-04-25 | 2004-10-15 | Pf Medicament | Pastille medicamenteuse a liberation lente du principe actif |
US20040107971A1 (en) | 2002-09-17 | 2004-06-10 | Abhijit De | Gum based chewing product and process for preparing the same |
NO346973B1 (en) * | 2002-12-20 | 2023-03-20 | Niconovum Ab | A physically and chemically stable nicotine-containing particulate material |
DE102005058569B4 (de) * | 2005-12-08 | 2010-07-15 | Lts Lohmann Therapie-Systeme Ag | Schaumwafer mit Polyvinylalkohol-Polyethylenglycol-Pfropfcopolymer |
ITTV20060039A1 (it) | 2006-03-14 | 2007-09-15 | Nice Spa | Sistema di controllo per uno o piu' azionamenti. |
US20090214442A1 (en) | 2006-12-01 | 2009-08-27 | Cephalon, Inc. | Oral Transmucosal Nicotine Dosage Form |
AR071420A1 (es) | 2008-05-01 | 2010-06-16 | Smithkline Beecham Corp | Composicion de pastilla para chupar oral que comprende un principio activo de nicotina y procedimiento para fabricarla |
US20100124560A1 (en) * | 2008-11-14 | 2010-05-20 | Mcneil Ab | Multi portion intra-oral dosage form and use thereof |
-
2010
- 2010-01-12 UA UAA201304861A patent/UA112974C2/uk unknown
- 2010-12-01 WO PCT/IN2010/000775 patent/WO2012035541A1/en active Application Filing
- 2010-12-01 US US13/513,463 patent/US9180124B2/en active Active
- 2010-12-01 BR BR112012031102A patent/BR112012031102B8/pt active IP Right Grant
- 2010-12-01 CA CA2782734A patent/CA2782734C/en active Active
- 2010-12-01 AU AU2010360967A patent/AU2010360967B2/en active Active
- 2010-12-01 MX MX2012012973A patent/MX339470B/es active IP Right Grant
- 2010-12-01 EA EA201390394A patent/EA025779B1/ru unknown
- 2010-12-01 EP EP10857212.4A patent/EP2496083A4/en not_active Ceased
-
2012
- 2012-09-03 ZA ZA2012/06589A patent/ZA201206589B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2496083A1 (en) | 2012-09-12 |
MX2012012973A (es) | 2013-03-05 |
EA025779B1 (ru) | 2017-01-30 |
BR112012031102B8 (pt) | 2021-05-25 |
MX339470B (es) | 2016-05-27 |
US20120244104A1 (en) | 2012-09-27 |
CA2782734A1 (en) | 2012-03-22 |
EP2496083A4 (en) | 2013-05-01 |
AU2010360967A1 (en) | 2012-07-05 |
ZA201206589B (en) | 2014-02-26 |
US9180124B2 (en) | 2015-11-10 |
BR112012031102B1 (pt) | 2021-05-18 |
WO2012035541A1 (en) | 2012-03-22 |
CA2782734C (en) | 2018-03-27 |
EA201390394A1 (ru) | 2013-07-30 |
AU2010360967B2 (en) | 2015-08-20 |
BR112012031102A2 (pt) | 2015-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA112974C2 (uk) | Нікотиновмісна композиція (варіанти) | |
WO2008085765A3 (en) | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain | |
WO2012092594A3 (en) | Preparations for topical prevention and/or treatment of oral allergic symptoms due to oral contact with fruits and/or vegetables | |
WO2014207770A8 (en) | A medicinal composition of amaranth extract origin having enriched nitrate content and a method of preparing the same | |
MY139913A (en) | Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance | |
WO2007125545A3 (en) | Transmucosal composition | |
WO2012079092A3 (en) | Testosterone undecanoate compositions | |
WO2010039762A3 (en) | Pharmaceutical compositions comprising boronic acid compounds | |
MX2008000087A (es) | Formulaciones orales rapidamente absorbentes de inhibidores de la fosfodiesterasa 5. | |
WO2007012019A3 (en) | Medicaments containing famotidine and ibuprofen and administration of same | |
WO2011146876A3 (en) | Oral transmucosal administration of sufentanil | |
MX342986B (es) | Formulaciones para el tratamiento de las afecciones de las vias aereas superiores. | |
MX2015008837A (es) | Composiciones parenterales estables de dnj. | |
RU2007107368A (ru) | Композиция, содержащая десмопрессин | |
WO2008087323A3 (fr) | Forme galenique pour l'administration par voie trans-muqueuse de paracetamol | |
WO2006100595A3 (en) | Chewing gum compositions of varenicline | |
EA201170108A1 (ru) | Сосательная композиция для лечения воспалительных заболеваний полости рта и глотки | |
TN2015000267A1 (en) | Solid unit with high fexofenadine content and process for the preparation thereof | |
MX2011012114A (es) | Solucion farmaceutica bebible de telmisartan. | |
PL2252263T3 (pl) | Postać galenowa do podawania tryptanów poprzez błonę śluzową policzka | |
CN102342896A (zh) | 一种生物酶漱口水 | |
WO2010135505A3 (en) | Crystalline forms of 4-[6-(6-methanesulfonyl-2-methylpyridin-3-ylamino)-5-methoxy-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid isopropyl ester | |
WO2008105533A1 (ja) | カプシノイド化合物含有アディポネクチン分泌促進剤 | |
MX2013007232A (es) | Composicion farmaceutica de fosfomicina. | |
WO2011161223A3 (en) | Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts |